Introduction {#s01}
============

G protein--coupled receptors (GPCRs) transduce the majority of signals in the human body. Activated receptors are removed from the cell surface by clathrin-mediated endocytosis ([@bib43]; [@bib20]; [@bib50]; [@bib12]; [@bib38]). Endocytosed GPCRs are transported to the endosome, from where they are either recycled back to the cell surface or degraded in the lysosome ([@bib22]; [@bib12]; [@bib26]; [@bib44]).

GPCR recycling requires specific sequences on the receptors and multiple interacting proteins ([@bib12]; [@bib35]; [@bib25]). Many other proteins that recycle as part of the bulk membrane flow without apparent sequence requirements or interactions ([@bib28]; [@bib27]). Furthermore, sequence-dependent recycling of GPCRs is mediated by tubular microdomains that are spatially and biochemically distinct from the tubular domains that mediate bulk recycling on the same endosome ([@bib34]). Previous work has defined how GPCRs are sorted into sequence-dependent recycling domains ([@bib34]; [@bib39]). Why GPCRs need a specialized recycling pathway, however, is not clear.

The role of endocytic trafficking has been redefined by data indicating that GPCRs can signal from endosomes ([@bib41]; [@bib46]). Although endosomal signaling has been well appreciated for some GPCRs, such as parathyroid hormone receptors ([@bib31]; [@bib1]; [@bib8]; [@bib45]), recent evidence suggests that this might be a general paradigm for GPCRs, as canonical GPCRs like β-2 adrenergic receptors (B2ARs) might also signal through G proteins on the endosome ([@bib17]). A conformation-specific nanobody biosensor that recognizes the nucleotide-free form of the Gα stimulatory protein (Gαs) showed that B2AR can support active exchange of G proteins on endosomes ([@bib17]). Furthermore, optogenetically engineered production of cAMP, the second messenger downstream of Gαs, at endosomes induced the expression of distinct gene targets compared with cAMP production at the plasma membrane, suggesting that the site of signal origin determines specific downstream consequences ([@bib40]).

In this study, we asked whether sequence-dependent endosomal microdomains play a role in coordinating endosomal signaling. We show that endosomal G protein signaling is restricted to actin/sorting nexin/retromer tubular (ASRT) endosomal microdomains. PKA phosphorylation of B2AR on its C-terminal tail increases the proportion of B2AR localized to ASRT microdomains and generates an endosomal bias in B2AR signaling, increasing transcription of genes specifically controlled by endosome-derived cAMP. Our results reveal a physiological reason for why separate recycling pathways evolved for signaling receptors and nutrient receptors.

Results and discussion {#s02}
======================

We first asked whether B2AR endosomal signaling was restricted to functional tubular domains. We directly quantitated agonist-induced redistribution of B2AR between endosomal microdomains in living cells in real time using live-cell confocal fluorescence microscopy in HEK 293 cells stably expressing fluorescently tagged B2AR. We and others have confirmed that this system accurately reflects the trafficking and signaling of B2AR ([@bib19]; [@bib36]; [@bib52]; [@bib34]; [@bib11]; [@bib42]). B2AR localized to the cell surface before addition of the B2AR agonist, isoproterenol (iso; [Fig. 1 A](#fig1){ref-type="fig"}). 5-min incubation with iso caused endocytosis and redistributed B2ARs to endosomes ([Fig. 1 A](#fig1){ref-type="fig"}). Within endosomal membranes, B2AR localized to tubular structures---previously characterized as ASRT domains that mediate sequence-dependent recycling---that are biochemically distinct from tubules that mediate constitutive recycling ([@bib34]; [@bib42]). PKA inhibition increased the percentage of B2AR endosomes with more than one B2AR tubule ([Fig. 1 A](#fig1){ref-type="fig"} and [Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp1}), consistent with B2AR sorting into both ASRT domains and constitutive tubules ([@bib34]; [@bib42]).

![**B2AR phosphorylation at S345 and S346 restricts B2AR to ASRT endosomal microdomains.** (A) Images of iso-induced B2AR endocytosis and PKA inhibition. Before iso, B2ARs localize to the cell surface. 5 min after iso, B2AR redistributes to endosomes and is sorted into tubules (arrowheads). KT was added 5 min after iso. Bars: (main images) 5 µm; (insets) 2 µm. (B) Example images of B2AR and coronin (ASRT marker) with iso and KT. KT causes B2AR to enter non-ASRT domains. (C) Quantitation of percent B2AR in ASRT and non-ASRT tubules. *n* = 31 (−KT, iso) and 14 (KT) cells. (D) Example images of B2AR and SNX1 (ASRT marker) with iso and KT. (B and D) Arrowheads show B2AR in ASRT domains, and arrows show B2AR in non-ASRT domains. Bars, 2 µm. (E) Quantitation of the percent B2AR in ASRT and non-ASRT tubules. *n* = 11 (−KT, iso only) and 18 (+KT, PKA inhibited) cells. (F) 5 min after iso, SS\>AA also localized to endosomes and tubules. Bars, 5 µm. (G) Example images of B2AR and SS\>AA with coronin. SS\>AA localizes to both ASRT domains (arrowheads) and constitutive tubules (arrows). Bars, 2 µm. (H) Quantitation of percent B2AR and SS\>AA ASRT tubules. SS\>AA localizes to both ASRT and non-ASRT tubules. *n* = 13 (B2AR) and 14 (SS\>AA) cells. Error bars in all graphs are SEM across cells.](JCB_201512068_Fig1){#fig1}

To estimate the proportion of B2ARs that localized to ASRT domains, we measured B2AR colocalization with established biochemical markers of these domains: coronin, cortactin, and sorting nexin 1 (SNX1; [@bib34]; [@bib39]). 5 min after iso addition, virtually all B2AR tubular domains colocalized with coronin ([Fig. 1, B and C](#fig1){ref-type="fig"}) and SNX1 ([Fig. 1, D and E](#fig1){ref-type="fig"}), indicating that B2AR was sorted primarily into ASRT domains. After PKA inhibition with the drug KT5720 (KT), ∼50% of B2AR tubular domains were devoid of coronin and SNX1 ([Fig. 1, B--E](#fig1){ref-type="fig"}; and [Fig. S1, B and C](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp2}). We observed a similar redistribution away from ASRT domains when two PKA target sites, S345 and S346, on the C-terminal tail of B2AR were mutated to alanine (SS\>AA), consistent with published data that PKA phosphorylation restricts B2AR to ASRT domains ([Fig. 1, F--H](#fig1){ref-type="fig"}; and [Fig. S1, D and E](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp3}; [@bib42]). This PKA phosphorylation-mediated relocation of B2AR provided us with an experimental setup to test the functional relevance of B2AR sorting to ASRT domains.

To test whether B2AR endosomal signaling could be spatially resolved in the context of endosomal microdomains, we used a GFP-tagged nanobody biosensor, Nb80, that recognizes the agonist-activated conformation of B2AR ([@bib47]; [@bib17]). Nb80 was recruited to B2AR endosomes 5 min after iso stimulation ([Fig. 2 A](#fig2){ref-type="fig"}), consistent with previous data that B2ARs exist in an active conformation at endosomes ([@bib17]). Nb80 localized to all domains of the endosome that contained B2AR, including the ASRT microdomains and constitutive tubules containing SS\>AA ([Fig. 2, B and C](#fig2){ref-type="fig"}; and [Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp4}), suggesting that B2AR is in an active conformation in all regions of the endosome, irrespective of whether B2AR was sorted to sequence-dependent or constitutive recycling tubules. As a direct readout of where Gαs was active, we used GFP-tagged Nb37, a nanobody that recognizes the nucleotide-free form of Gαs ([@bib17]). In contrast to Nb80, Nb37 localized to punctate regions on the endosome at the base of B2AR recycling tubules ([Fig. 2, D and E](#fig2){ref-type="fig"}). Nb37 localization was largely restricted to domains containing the ASRT domain marker cortactin ([Fig. 2, E and F](#fig2){ref-type="fig"}; and [Fig. S2 B](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp5}). Interestingly, Nb37 was still localized only to ASRT domains in SS\>AA endosomes, even when active receptors were partitioned to both ASRT domains and constitutive tubules were not marked by ASRT components ([Fig. 2 E](#fig2){ref-type="fig"}). 50% of the SS\>AA tubules were devoid of both Nb37 and cortactin markers ([Fig. 2 F](#fig2){ref-type="fig"} and [Fig. S2 B](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp6}). The distinct localization patterns of the nanobodies that detect active receptor and active Gαs indicate that Gαs activation is restricted to ASRT domains, even though B2AR may be in an active conformation in a broader region of the endosome.

![**B2AR activates Gαs exclusively in ASRT endosomal microdomains.** (A) Example images of B2AR, an ASRT marker; cortactin; and Nb80. Nb80 localizes to endosomes and tubules (arrowheads). Bars, 5 µm. (B) Example images of B2AR and SS\>AA with cortactin and Nb80. Nb80 localizes to ASRT (arrowheads) and non-ASRT SS\>AA tubules (arrows). Bars, 2 µm. (C) Percent tubules per cell with cortactin and Nb80, cortactin or Nb80 only, or neither. *n* = 15 (B2AR) and 21 (SS\>AA) cells. (D) Example images of B2AR, cortactin, and Nb37. Nb37 localizes exclusively to the base of B2AR tubules (arrowheads) with cortactin (ASRT). Bars, 5 µm. (E) Example images of B2AR and SS\>AA with cortactin and Nb37. Nb37 is not recruited to SS\>AA constitutive tubules (arrows). Arrowheads show B2AR in ASRT domains. Bars, 2 µm. (F) Quantitation of the percentage of total tubules per cell that contain cortactin and Nb37, cortactin or Nb37 only, or neither. *n* = 42 (B2AR) and 43 (SS\>AA) cells.](JCB_201512068_Fig2){#fig2}

To confirm that phosphorylation of B2AR at S345 and S346 confines Gαs activation to ASRT domains, we generated a phosphomimetic version of B2AR, mutating both S345 and S346 to aspartic acid (SS\>DD). SS\>DD localized exclusively to ASRT domains ([Fig. 3 A](#fig3){ref-type="fig"}). Importantly, unlike wild-type B2AR, PKA inhibition did not redistribute SS\>DD into constitutive tubules ([Fig. 3, A and B](#fig3){ref-type="fig"}), suggesting that phosphorylation of S345 and S346 directly regulates the sorting of B2AR into ASRT domains. Nb37 was recruited only to B2AR and to SS\>DD domains overlapping with cortactin ([Fig. 3, C and D](#fig3){ref-type="fig"}; and [Fig. S2 B](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp7}), together suggesting that B2ARs, when phosphorylated at S345 and S346, are sorted into ASRT domains, where they activate Gαs. ASRT domains therefore might function as specific scaffolds for recruiting G proteins to the endosome.

![**A phosphomimetic B2AR mutant is restricted to ASRT domains independent of PKA and activates Gαs in ASRT domains.** (A) Example images of B2AR and SS\>DD ASRT (arrowheads) and non-ASRT (arrows) tubules after iso and before and after KT. Bar, 2 µm. (B) Percent ASRT tubules (marked by coronin) and non-ASRT tubules for B2AR and SS\>DD with and without KT. KT does not cause SS\>DD to enter non-ASRT tubules. *n* = 43 (B2AR − KT), 26 (B2AR + KT), 64 (SS\>DD − KT), and 36 (SS\>DD + KT) cells. n.s., not significant. (C) Example images of FLAG-B2AR and SS\>DD with cortactin and Nb37 after iso. Nb37 is recruited to SS\>DD ASRT tubules (arrowheads). Bar, 2 µm. (D) Percent tubules per cell that contain cortactin and Nb37, cortactin or Nb37 only, or neither marker. *n* = 42 (B2AR) and 47 (SS\>DD) cells. Error bars in all graphs are SEM across cells.](JCB_201512068_Fig3){#fig3}

Emerging data indicate that production of cAMP signaling at the endosome and the cell surface have distinct downstream effects, as they activate the transcription of different sets of downstream genes ([@bib40]). Based on our data that Nb37 was not recruited to constitutive recycling tubules ([Fig. 2, D--F](#fig2){ref-type="fig"}), we hypothesized that the strength of endosomal G protein signaling could be controlled by the dynamic relocation of B2AR to constitutive recycling tubules. To test this, we measured total cAMP response in conditions where B2AR localized exclusively to ASRT domains or to bulk recycling domains. We used a Forster resonance energy transfer (FRET)--based sensor ([@bib6]; [@bib33]), which measures cAMP-induced conformational changes in exchange proteins activated by cAMP (Epac's), to resolve cAMP production over time. When cells expressing this sensor and either B2AR or SS\>AA were exposed to iso, cAMP levels increased within 2 min. This increase was sustained over 25 min, and B2AR endocytosis was visible within 2 min of iso stimulation in the same cells ([Fig. 4, A and B](#fig4){ref-type="fig"}). Total cAMP increased significantly for both B2AR and SS\>AA to a similar degree 20 min after iso ([Fig. 4 C](#fig4){ref-type="fig"}), indicating that the SS\>AA was fully competent to signal through cAMP, comparable to B2AR.

![**The localization of B2AR to ASRT or bulk recycling domains does not influence global cAMP levels.** (A) Example images of Epac and B2AR. 1--2 min after iso, the CFP/FRET ratio increases as cAMP is produced and FRET decreases. Bar, 10 µm. (B) CFP/FRET ratio across multiple B2AR cells. Error bars are SEM across cells. *n* = 10 cells. (C) The total cAMP produced at 20 min increased significantly for both B2AR and SS\>AA. Data are Tukey box plots from 13 (B2AR) and 10 (SS\>AA) cells.](JCB_201512068_Fig4){#fig4}

To test whether endosome-specific cAMP responses were regulated by PKA-mediated B2AR relocation, we used reverse transcription followed by quantitative real-time PCR to measure the expression of three genes---PCK1 (phosphoenolpyruvate carboxykinase 1), CGA (glycoprotein hormones, α-polypeptide), and NR4A1 (nuclear receptor subfamily 4 group A member 1)---that are induced specifically by endosomal cAMP ([@bib40]). We isolated RNA from HEK 293 cells stably expressing wild-type B2AR or SS\>AA and measured the expression of PCK1 as well as the reference gene, β-tubulin (TUBB). Dose--response curve analysis showed that TUBB expression changed in a similar concentration-dependent manner with and without iso treatment ([Fig. S3, D and E](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp8}), making it a suitable gene to normalize the expression of iso-dependent genes across treatments. When normalized to TUBB expression, PCK1, CGA, and NR4A1 expression levels increased by approximately five-, six-, and eightfold upon B2AR activation by iso ([Fig. 5, A--C](#fig5){ref-type="fig"}).

![**B2AR localization to ASRT domains correlates with expression of endosomal cAMP-specific genes.** (A--C) Tukey box plots of fold change in PCK1 (A), CGA (B), and NR4A1 (C) expression across multiple experimental replicates. Iso increased PCK1 expression. Dynasore, Dyngo-4a, dynamin-K44A, or latA prevented the iso-induced increase in PCK1 expression. *n* = 11 for iso, iso + dynasore, and iso + latA, and *n* = 6 for all others. (D--F) Fold change in PCK1 (D), CGA (E), and NR4A1 (F) expression with iso for B2AR, SS\>AA, and SS\>DD. Iso increased PCK1 expression for B2AR and SS\>DD, but not for SS\>AA. *n* = 14 for B2AR and SS\>AA, and *n* = 6 for SS\>DD. Dashed lines throughout indicate the location of value 1 on the y axis. In all cases, p-values in relation to iso treatment alone are shown.](JCB_201512068_Fig5){#fig5}

We then used three independent methods to block receptor endocytosis: dynasore and Dyngo-4a, two inhibitors of dynamin-dependent endocytosis ([@bib24]; [@bib14]; [@bib29]), and expression of the dominant-negative mutant of dynamin, dynamin K44A ([@bib16]; [@bib5]). All of these ablated the iso-induced increase in PCK1 expression, showing that it required receptor endocytosis ([Fig. 5 A](#fig5){ref-type="fig"}; [@bib40]). As a control, pretreatment with Dyngo-4a did not cause a significant decrease in iso-induced whole-cell cAMP levels as measured by the Epac sensor ([Fig. S3 C](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp9}). These results support the model that, although the majority of overall cAMP is derived from initial activation of receptors on the cell surface at this time point, endosome-derived cAMP is a functionally distinct pool ([@bib40]). Disruption of ASRT domains by latrunculin A (latA), an actin-depolymerizing agent, ablated the iso-induced increase in PCK1 expression ([Fig. 5 A](#fig5){ref-type="fig"}), suggesting that localization of B2AR to ASRT domains was required for induction of PCK1 expression. Addition of latA with iso to B2AR-expressing cells did not significantly change total cAMP produced 20 min after iso ([Fig. S3 C](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp10}), and internalization of B2AR was unaffected when cells were treated with iso and latA ([Fig. S3, A and B](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp11}). Iso-induced increases in CGA and NR4A1 expression were also dependent on endocytosis and intact ASRT domains ([Fig. 5, B and C](#fig5){ref-type="fig"}).

We next tested whether PCK1, CGA, and NR4A1 expression is regulated by partitioning B2AR between ASRT and bulk recycling microdomains. To do this, we used SS\>AA, the B2AR mutant that cannot be phosphorylated on S345/S346 by PKA and is not restricted from entering bulk tubules. Strikingly, SS\>AA activation did not increase expression of endocytosis-dependent genes ([Fig. 5, D--F](#fig5){ref-type="fig"}), indicating that SS\>AA does not sustain endosomal Gαs signaling to the same degree as wild-type B2AR. Furthermore, the SS\>DD phosphomimetic mutant increased the expression of PCK1, CGA, and NR4A1 comparable to the wild-type receptor ([Fig. 5, D--F](#fig5){ref-type="fig"}), strongly supporting our model that phosphorylation-dependent sorting of B2AR into ASRT domains facilitates B2AR endosomal Gαs signaling. These results, together with our data that total cAMP levels are not significantly different between B2AR and SS\>AA ([Fig. 4 C](#fig4){ref-type="fig"}), support the emerging model that endosomal cAMP might be a small but specialized pool of cAMP that has distinct downstream effects on gene activation.

Together, our data reveal a physiological reason for why two separate recycling pathways---sequence-dependent recycling for signaling receptors and bulk recycling for nutrient receptors---have evolved. We show that, although both pathways can support recycling of B2AR ([@bib42]), only the sequence-dependent pathway can support Gαs signaling from the endosome ([Fig. S3 F](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp12}). This might be the primary role of sequence-dependent recycling. The extent of B2AR partitioning between these two pathways is regulated by the phosphorylation state of a specific PKA target sequence on B2AR. This is a control point that determines the spatial bias of adrenergic signaling between surface and endosomal signals, and therefore the downstream complement of genes ([Fig. S3 F](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp13}). PKA is a major target of B2AR itself ([@bib2]; [@bib10]; [@bib21]), so this regulation might be a homeostatic mechanism that switches the pattern of downstream consequences based on whether there is a continued presence of agonists. Persistent adrenergic signals, by keeping B2AR in a phosphorylated state, might bias toward endosomal signals, whereas intermittent signals might bias toward surface signals by B2AR dephosphorylation, relocation to bulk tubules, and/or attenuation of endosomal Gαs signaling. This bias might also be controlled differentially by distinct agonists that activate PKA to various degrees. PKA activity is also regulated by other receptors, many of which are coexpressed and often coactivated in neurons and cardiac myocytes ([@bib22]; [@bib32]; [@bib9]; [@bib21]), providing a potential mechanism for signaling cross talk.

Our results suggest that the availability of G proteins, and not receptor activation, is the limiting factor for signaling from the endosome. Although B2AR was in an active conformation on the entire endosome, based on Nb80 localization, G protein signaling, detected by Nb37, was restricted to ASRT domains. ASRT domains, in addition to their known roles in stabilizing sequence-dependent tubules and in sorting B2AR into these domains, could also serve as scaffolds to concentrate Gαs proteins, to be activated by B2AR. Interestingly, B2AR can couple to Gαi under some circumstances ([@bib49]; [@bib4]; [@bib48]), and this could be regulated by PKA phosphorylation ([@bib3]; [@bib15]; [@bib23]; [@bib30]; [@bib37]; [@bib53]). There are two separate PKA phosphorylation sites on B2AR: one at S261 and S262, and another at S345 and S346. Although the precise contributions of these sites have not been separated, G protein coupling seems to be primarily regulated by S261/S262 ([@bib3]; [@bib15]; [@bib51]). Consistent with the global cAMP changes seen in these studies, it is possible that S261/S262 regulates G protein coupling at the plasma membrane, whereas S345/S346 plays an analogous role on the endosome.

Spatial encoding of signals by membrane microdomains suggests that a primary role of membrane trafficking is to move GPCRs between signaling complexes. For example, B2AR may transfer from Gαs signaling to arrestin-mediated signaling in clathrin-coated pits at the plasma membrane, and later to a spatially discrete Gαs signaling complex in endosomal microdomains. Interestingly, in contrast to the activation seen with B2AR, localization of parathyroid hormone receptors to ASRT domains leads to termination of sustained cAMP signaling ([@bib7]). Because many GPCRs can signal from endosomes using multiple downstream factors ([@bib31]; [@bib1]; [@bib8]; [@bib45]; [@bib18]), microdomain localization is likely a general mechanism for regulating GPCR signaling, although the specific mechanisms might therefore vary between GPCRs. In any case, the efficiency of receptor partitioning between, and time spent in, distinct complexes might contribute significantly to the tuning of downstream effects separated in space and time. Identifying the molecular mechanisms involved in regulating endosomal sorting of GPCRs could provide candidates to manipulate receptor localization and generate strategies to spatially bias GPCR signaling in the future.

Materials and methods {#s03}
=====================

Constructs and reagents {#s04}
-----------------------

FLAG-B2AR (B2AR), FLAG-B2AR S345--S346A (SS\>AA), cortactin-DsRed, coronin-GFP, SNX1-GFP, and Epac CFP/YFP FRET sensor constructs have been described previously ([@bib6]; [@bib13]; [@bib34]; [@bib39]; [@bib42]). FLAG-B2AR S345-6D (SS\>DD) was created using the QuickChange site-directed mutagenesis protocol and Pfu Turbo polymerase (Agilent Technologies). Nb80- and Nb37-GFP plasmid constructs were gifts from R. Irannejad (University of California, San Francisco, San Francisco, CA) and M. von Zastrow (University of California, San Francisco, San Francisco, CA) and were described previously ([@bib17]). HEK 293 cells were obtained from ATCC and maintained in DMEM high glucose (Thermo Fisher Scientific) + 10% FBS (Gibco). Cells were transfected with Effectene (QIAGEN) according to the manufacturer's instructions. Stable cell lines of FLAG-B2AR and FLAG-B2AR S345--S346A were generated with Zeocin (Invitrogen) selection. FLAG-B2AR SS\>DD experiments were performed in transiently transfected cells and were assayed 48--96 h after transfection. Cells were passed to a 25-mm coverglass 1 d after transfection with actin or retromer markers, or with the Epac FRET sensor, and imaged 48--96 h after transfection.

Iso hydrochloride (Sigma-Aldrich) was prepared as a 10-mM stock in water, and KT (Santa Cruz Biotechnology, Inc.) was prepared as a 10-mM stock in DMSO. LatA (Cayman Chemical) was prepared at a concentration of 100 µg/ml in ethanol. These drugs were used at a final concentration of 10 µM. Dynasore hydrate was prepared fresh for each experiment, dissolved in DMSO, and used at a final concentration of 80 µM. Dyngo-4a was dissolved in DMSO and used at a final concentration of 30 µM.

Microscope image acquisition and analysis {#s05}
-----------------------------------------

Confocal images were acquired with a spinning disk system (Andor Revolution XD) on an inverted microscope (Eclipse T*i*; Nikon) equipped with a temperature-, humidity-, and CO~2~-controlled chamber and 60× or 100× 1.49 NA total internal reflection fluorescence (TIRF) objectives (Nikon). Images were acquired on an electron-multiplying charge-coupled device camera (iXon+ 897) using the Andor IQ software (Andor Technology). Cells were imaged live at 37°C in Leibovitz's L15-no phenol red (Gibco) with 1% FBS. Solid-state 488-nm, 561-nm, or 647-nm lasers served as light sources. HEK 293 cells stably expressing FLAG-B2AR were labeled for 10 min at 37°C in DMEM high glucose + 10% FBS with M1 anti-FLAG conjugated to Alexa Fluor 647 (Molecular Probes). Cells were imaged 5--15 min after the addition of iso and 2--5 min after the addition of KT. Stacks and time-lapse images were collected as TIFF images and analyzed with ImageJ (National Institutes of Health). Tubules and actin spots per endosome were counted blindly with scrambled file names. All fluorescence measurements and quantitations were performed on images acquired directly from the camera without adjustments. Simple statistical analyses were performed in Excel (Microsoft) and Prism (GraphPad Software). P-values were generated from unpaired Student's *t* tests.

cAMP measurements with Epac CFP/YFP FRET sensor {#s06}
-----------------------------------------------

Iso-induced cAMP production was measured in live cells with the Epac CFP/YFP FRET sensor ([@bib6]; [@bib33]). The Epac sensor contained a CFP (405-nm excitation and 470-nm emission) and YFP (515-nm excitation and 530-nm emission). After cAMP binding to Epac's cAMP-binding domain, a decrease in the FRET signal (CFP excitation at 405 nm and YFP emission at 530 nm) occurred, allowing cAMP production to be measured as a decrease in FRET, which was expressed as the CFP/FRET ratio. CFP and YFP images were acquired, in addition to images of anti-FLAG--Alexa Fluor 647--labeled FLAG-B2AR at 37°C, every 15 s in wide-field excitation using a 60× 1.49 NA TIRF objective (Nikon). Image analysis was performed in ImageJ. For Epac experiments with the drug Dyngo-4a, images were acquired using confocal fluorescence microscopy, rather than wide-field TIRF excitation, to prevent detection of autofluorescence produced by Dyngo-4a. HEK 293 cells stably expressing FLAG-B2AR or FLAG-B2AR--SS\>AA were treated with 30 µM Dyngo-4a only, or pretreated for 15 min before addition of 10 µM iso. In latA experiments, cells were treated with 10 µM iso and 10 µM latA simultaneously and imaged. CFP/FRET ratios were normalized to the mean of all time points before iso addition. The pre-iso time point ([Fig. 4 C](#fig4){ref-type="fig"} and [Fig. S3 C](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp14}) was 2.5 min before iso addition.

RNA isolation, reverse transcription, and quantitative, real-time PCR {#s07}
---------------------------------------------------------------------

RNA was harvested from HEK 293 cells 2 h after iso addition using the RNeasy Plus Mini kit (QIAGEN) according to the manufacturer's instructions. Cells were cotreated with latA and iso for 2 h. Cells were pretreated with 80 µM dynasore or 30 µM Dyngo-4a for 20 min and then treated with iso for 2 h before RNA isolation. For dynamin K44A experiments, cells were transfected with dynamin K44A-GFP 48 h before RNA isolation. RNA was treated with amplification-grade DNase I (Thermo Fisher Scientific), and reverse transcription was performed with the Superscript First Strand System for RT-PCR (Thermo Fisher Scientific). RNA was amplified using random hexamer primers (Thermo Fisher Scientific). cDNA was then treated with RNase H (Thermo Fisher Scientific) before quantitative PCR reactions. Primers for gene targets were chosen to amplify targets 50--100 bp and spanning an exon--exon junction. The following primers were used to amplify gene targets: TUBB forward (5′-GTGGTACGGAAGGAGGTCGATG-3′) and reverse (5′-AAGGTGACTGCCATCTTGAGG-3′); PCK1 forward (5′-CTGCCCAAGATCTTCCATGT-3′) and reverse (5′-CAGCACCCTGGAGTTCTCTC-3′); CGA forward (5′-TTCGGATCCACAGTCAACCG-3′) and reverse (5′-ATCCATGGCGCTCCTTTCTC-3′); and NR4A1 forward (5′-GACGGGATAATGTGGTTGGC-3′) and reverse (5′-GGCATCTCACTCTGGATGGA-3′). TUBB was chosen as the reference gene for normalization because its expression did not change significantly with iso addition ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp15}). SYBR green Select Master Mix (Thermo Fisher Scientific) was used for quantitative RT-PCR amplification and detection on a BioRad Cfx RT-PCR machine (Bio-Rad Laboratories).

Online supplemental material {#s08}
----------------------------

[Fig. S1](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp16} shows supporting data that PKA inhibition increases the number of B2AR tubules per endosome and shows the raw number of tubules per cell with ASRT markers, corresponding to the normalized data in [Fig. 1](#fig1){ref-type="fig"}. [Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp17} shows the number of tubules per cell with ASRT markers, corresponding to the normalized data in [Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}. In relation to [Fig. 4](#fig4){ref-type="fig"}, [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp18} shows that latA addition with iso does not significantly alter B2AR endocytosis or the iso-dependent increase in cAMP and that pretreatment with Dyngo-4A does not significantly alter iso-induced cAMP production. In relation to [Fig. 5](#fig5){ref-type="fig"}, [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp19} shows that TUBB expression is not significantly altered by iso and is therefore a suitable reference gene for normalization. [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201512068/DC1){#supp20} also suggests a model for how spatial encoding of B2AR signaling can create a bias toward endosomal or cell surface signaling responses. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201512068/DC1>.
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